Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: The evidence, current practice and future challenges

Journal of Viral Hepatitis

Volumn 21, Issue 6, 2014, Pages 381-396

  Howell, J ^a,b,c,d   Lemoine, M ^a,b   Thursz, M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c BURNET INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

antenatal screening; HIV; immunization; liver disease; pregnancy; preventive health; vertical transmission; viral hepatitis

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B VACCINE; LAMIVUDINE; TELBIVUDINE;

AFRICA SOUTH OF THE SAHARA; HEALTH; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; LIVER CANCER; MATERNO FETAL TRANSMISSION; PERINATAL PERIOD; PRACTICE GUIDELINE; PREGNANT WOMAN; PREVALENCE; PREVENTION; PRIORITY JOURNAL; REVIEW; RISK; VACCINATION; VERTICAL TRANSMISSION; VIRUS CARRIER; VIRUS TRANSMISSION; EPIDEMIOLOGY; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION; UTILIZATION; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; GUIDELINES AS TOPIC; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84900839982     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12263     Document Type: Review

References (168)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55 (2): 74-108. (Pubitemid 40372904)
2. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H,. Part I: cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 2008; 9 (7): 683-692. (Pubitemid 351878054)
3. Kirk GD, Lesi OA, Mendy M, et al,. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004; 39 (1): 211-219. (Pubitemid 38461484)
4. Jemal A, Bray F, Forman D, et al,. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118 (18): 4372-4384.
5. Ekra D, Herbinger KH, Konate S, et al,. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. Vaccine 2008; 26 (22): 2753-2761.
6. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79 (28): 255-263.
7. MacIntyre CR,. Hepatitis B vaccine: risks and benefits of universal neonatal vaccination. J Paediatr Child Health 2001; 37 (3): 215-217.
8. Thursz M, Njie R, Lemoine M,. Hepatitis: global eradication of hepatitis B-feasible or fallacy? Nat Rev Gastroenterol Hepatol 2012; 9 (9): 492-494.
9. Mansoor OD, Salama P,. Should hepatitis B vaccine be used for infants? Expert Rev Vaccines 2007; 6 (1): 29-33. (Pubitemid 46232478)
10. Mahoney FJ,. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12 (2): 351-366. (Pubitemid 29196857)
11. Kane M,. Global programme for control of hepatitis B infection. Vaccine 1995; 13 (Suppl. 1): S47-S49.
12. Chan HL, Thompson A, Martinot-Peignoux M, et al,. Hepatitis B surface antigen quantification: why and how to use it in 2011-a core group report. J Hepatol 2011; 55 (5): 1121-1131.
13. Brunetto MR, Oliveri F, Coco B, et al,. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002; 36 (2): 263-270. (Pubitemid 34146434)
14. Van Herck K, Van Damme P,. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J 2008; 27 (10): 861-869.
15. Wang JS, Zhu QR,. Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 2000; 355 (9208): 989.
16. Mast EE, Alter MJ, Margolis HS,. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17 (13-14): 1730-1733. (Pubitemid 29138908)
17. Cutts FT, Hall AJ,. Vaccines for neonatal viral infections: hepatitis B vaccine. Expert Rev Vaccines 2004; 3 (4): 349-352. (Pubitemid 39061694)
18. Shi Z, Yang Y, Ma L, Li X, Schreiber A,. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 2010; 116 (1): 147-159.
19. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS,. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166 (8): 813-818. (Pubitemid 46988175)
20. Singh AE, Plitt SS, Osiowy C, et al,. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011; 18 (7): 468-473.
21. Yin Y, Wu L, Zhang J, Zhou J, Zhang P, Hou H,. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect 2013; 66 (5): 447-452.
22. Wiseman E, Fraser MA, Holden S, et al,. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190 (9): 489-492.
23. Guo Z, Shi XH, Feng YL, et al,. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat 2013; 20 (5): 317-321.
24. Zou H, Chen Y, Duan Z, Zhang H, Pan C,. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012; 19 (2): e18-e25.
25. Chen HL, Lin LH, Hu FC, et al,. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142 (4): 773-781.
26. Wang Z, Zhang J, Yang H, et al,. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003; 71 (3): 360-366. (Pubitemid 37176624)
27. Beasley RP, Trepo C, Stevens CE, Szmuness W,. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105 (2): 94-98. (Pubitemid 8042976)
28. Xu ZY, Liu CB, Francis DP, et al,. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 1985; 76 (5): 713-718. (Pubitemid 16244995)
29. Ott JJ, Stevens GA, Groeger J, Wiersma ST,. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30 (12): 2212-2219.
30. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al,. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. J Infect Dis 2009; 200 (1): 33-38.
31. Beasley RP, Hwang LY, Lee GC, et al,. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2 (8359): 1099-1102. (Pubitemid 14242389)
32. Wong VC, Ip HM, Reesink HW, et al,. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984; 1 (8383): 921-926. (Pubitemid 14136295)
33. Lo KJ, Tsai YT, Lee SD, et al,. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985; 152 (4): 817-822. (Pubitemid 16215962)
34. Assateerawatt A, Tanphaichitr VS, Suvatte V, In-ngarm L,. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates. Asian Pac J Allergy Immunol 1991; 9 (2): 89-93.
35. Poovorawan Y, Sanpavat S, Pongpunglert W, et al,. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992; 11 (10): 816-821.
36. Mast EE, Margolis HS, Fiore AE, et al,. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54 (RR-16): 1-31.
37. Gambarin-Gelwan M,. Hepatitis B in pregnancy. Clin Liver Dis 2007; 11 (4): 945-963, x. (Pubitemid 350019024)
38. Liang X, Bi S, Yang W, et al,. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200 (1): 39-47.
39. Lee C, Gong Y, Brok J, Boxall EH, Gluud C,. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332 (7537): 328-336.
40. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al,. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011; 18 (5): 369-375.
41. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y,. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine 2009; 27 (44): 6110-6115.
42. Koff RS,. Hepatitis vaccines: recent advances. Int J Parasitol 2003; 33 (5-6): 517-523. (Pubitemid 36638534)
43. Keating GM, Noble S,. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63 (10): 1021-1051. (Pubitemid 36575466)
44. Tajiri H, Tanaka H, Brooks S, Takano T,. Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers. Cancer Causes Control 2011; 22 (3): 523-527.
45. Pan CQ, Duan ZP, Bhamidimarri KR, et al,. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012; 10 (5): 452-459.
46. Borresen ML, Koch A, Biggar RJ, et al,. Effectiveness of the targeted hepatitis B vaccination program in Greenland. Am J Public Health 2012; 102 (2): 277-284.
47. Xu H, Zeng T, Liu JY, et al,. Measures to reduce mother-to-child transmission of hepatitis B virus in China: a meta-analysis. Dig Dis Sci 2013; 59 (2): 242-258.
48. Postvaccination serologic testing results for infants aged
49. Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G,. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002; 20 (31-32): 3739-3743. (Pubitemid 35223404)
50. Yuan J, Lin J, Xu A, et al,. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13 (9): 597-604. (Pubitemid 44232543)
51. Xiao XM, Li AZ, Chen X, Zhu YK, Miao J,. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96 (3): 167-170. (Pubitemid 46281912)
52. Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW,. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17 (38): 4321-4333.
53. Kose S, Turken M, Devrim I, Taner C,. Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants. J Infect Dev Ctries 2011; 5 (4): 303-306.
54. Xu WM, Cui YT, Wang L, et al,. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16 (2): 94-103.
55. Brown RS Jr, Verna EC, Pereira MR, et al,. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry. J Hepatol 2012; 57 (5): 953-959.
56. Pan CQ, Mi LJ, Bunchorntavakul C, et al,. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci 2012; 57 (9): 2423-2429.
57. Nurutdinova D, Onen NF, Hayes E, Mondy K, Overton ET,. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants. Ann Pharmacother 2008; 42 (11): 1581-1585.
58. Pan CQ, Han GR, Jiang HX, et al,. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol 2012; 10 (5): 520-526.
59. Han GR, Cao MK, Zhao W, et al,. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55 (6): 1215-1221.
60. Liu MH, Sheng YJ, Liu JY, Hu HD, Zhang QF, Ren H,. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Ann Saudi Med 2013; 33 (2): 169-176.
61. Liu M, Cai H, Yi W,. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy. J Viral Hepat 2013; 20 (Suppl. 1): 65-70.
62. Sokal EM, Paganelli M, Wirth S, et al,. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol 2013; 59 (4): 814-829.
63. Yang J, Zeng XM, Men YL, Zhao LS,. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review. Virol J 2008; 5: 100.
64. Hu Y, Chen J, Wen J, et al,. Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus. BMC Pregnancy Childbirth 2013; 13 (1): 119.
65. Chen X, Chen J, Wen J, et al,. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus. PLoS ONE 2013; 8 (1): e55303.
66. Woo D, Cummins M, Davies PA, Harvey DR, Hurley R, Waterson AP,. Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals. Arch Dis Child 1979; 54 (9): 670-675. (Pubitemid 9247553)
67. Beasley RP, Stevens CE, Shiao IS, Meng HC,. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975; 2 (7938): 740-741.
68. Marion SA, Tomm Pastore M, Pi DW, Mathias RG,. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994; 140 (8): 734-746. (Pubitemid 24322186)
69. Expanded programme on immunization. Global Advisory Group-Part I. Wkly Epidemiol Rec 1992; 67 (3): 11-15.
70. Banatvala J, Van Damme P, Emiroglu N,. Hepatitis B immunisation in Britain: time to change? BMJ 2006; 332 (7545): 804-805. (Pubitemid 44365611)
71. Montesano R,. Hepatitis B immunization and hepatocellular carcinoma: the Gambia Hepatitis Intervention Study. J Med Virol 2002; 67 (3): 444-446.
72. Mendy M, D'Mello F, Kanellos T, Oliver S, Whittle H, Howard CR,. Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections. J Med Virol 2008; 80 (9): 1537-1546.
73. Mendy M, Peterson I, Hossin S, et al,. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS ONE 2013; 8 (3): e58029.
74. van der Sande MA, Waight P, Mendy M, et al,. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193 (11): 1528-1535. (Pubitemid 43794582)
75. van der Sande MA, Waight PA, Mendy M, et al,. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS ONE 2007; 2 (8): e753.
76. Chakvetadze C, Roussin C, Roux J, Mallet V, Petinelli ME, Pol S,. Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers. Vaccine 2011; 29 (16): 2846-2849.
77. Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K,. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district. Ann Trop Med Parasitol 2009; 103 (6): 519-527.
78. Kim SY, Salomon JA, Goldie SJ,. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ 2007; 85 (11): 833-842. (Pubitemid 350086455)
79. Klingler C, Thoumi AI, Mrithinjayam VS,. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. Vaccine 2012; 31 (1): 252-259.
80. Burnett RJ, Kramvis A, Dochez C, Meheus A,. An update after 16 years of hepatitis B vaccination in South Africa. Vaccine 2012; 30 (Suppl. 3): C45-C51.
81. Coates T, Wilson R, Patrick G, Andre F, Watson V,. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001; 23 (3): 392-403. (Pubitemid 32328745)
82. Bruguera M, Cremades M, Salinas R, Costa J, Grau M, Sans J,. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992; 14 (1): 27-30.
83. Arrazola MP, de Juanes JR, Ramos JT, Aragon AJ, Garcia de Codes A,. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Med Virol 1995; 45 (3): 339-341.
84. Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K,. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. J Med Assoc Thai 2002; 85 (3): 277-282. (Pubitemid 34875593)
85. Pasricha N, Datta U, Chawla Y, et al,. Poor responses to recombinant HBV vaccination in patients with HIV infection. Trop Gastroenterol 2005; 26 (4): 178-182.
86. Simani OE, Leroux-Roels G, Francois G, Burnett RJ, Meheus A, Mphahlele MJ,. Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic. Vaccine 2009; 27 (1): 146-151.
87. Mutwa PR, Boer KR, Rusine JB, et al,. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda. Pediatr Infect Dis J 2013; 32 (3): 246-251.
88. Pippi F, Bracciale L, Stolzuoli L, et al,. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. HIV Med 2008; 9 (7): 519-525.
89. Aidaoui M, Bouzbid S, Laouar M,. [Seroprevalence of HIV infection in pregnant women in the Annaba region (Algeria)]. Rev Epidemiol Sante Publique 2008; 56 (4): 261-266.
90. Onakewhor JU, Olagbuji BN, Okpere EE,. Pattern and risk factors for partner infection with hepatitis B virus in a prevention of mother-to-child transmission programme. West Afr J Med 2013; 32 (2): 110-114.
91. Ilboudo D, Karou D, Nadembega WM, et al,. Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the mother-to-child HIV transmission prevention program at Saint Camille Medical Centre in Burkina Faso. Pak J Biol Sci 2007; 10 (17): 2831-2837. (Pubitemid 47597070)
92. Simpore J, Granato M, Santarelli R, et al,. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 2004; 31 (1): 78-80. (Pubitemid 39024390)
93. Simpore J, Savadogo A, Ilboudo D, et al,. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006; 78 (6): 730-733.
94. Sangare L, Sombie R, Combassere AW, et al,. Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull Soc Pathol Exot 2009; 102 (4): 226-229.
95. Ouermi D, Simpore J, Belem AM, et al,. Co-infection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso. Pak J Biol Sci 2009; 12 (17): 1188-1193.
96. Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T,. Prevalence, correlates and pattern of hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth 2013; 13 (1): 158.
97. Kfutwah AK, Tejiokem MC, Njouom R,. A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virol J 2012; 9: 62.
98. Ducancelle A, Abgueguen P, Birguel J, et al,. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS ONE 2013; 8 (11): e80346.
99. Noubiap JJ, Joko WY, Nansseu JR, Tene UG, Siaka C,. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edea, Cameroon. Int J Infect Dis 2013; 17 (10): e832-e837.
100. Laurent C, Bourgeois A, Mpoudi-Ngole E, et al,. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. HIV Med 2010; 11 (1): 85-89.
101. Zoufaly A, Onyoh EF, Tih PM, Awasom CN, Feldt T,. High prevalence of hepatitis B and syphilis co-infections among HIV patients initiating antiretroviral therapy in the north-west region of Cameroon. Int J STD AIDS 2012; 23 (6): 435-438.
102. Komas NP, Bai-Sepou S, Manirakiza A, Leal J, Bere A, Le Faou A,. The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic. BMC Infect Dis 2010; 10: 226.
103. Itoua-Ngaporo A, Sapoulou MV, Ibara JR, Iloki LH, Denis F,. Prevalence of hepatitis B viral markers in a population of pregnant women in Brazzaville (Congo). J Gynecol Obstet Biol Reprod (Paris) 1995; 24 (5): 534-536.
104. Namululi BA, Guerrieri C, Dramaix M,. Impact of method of recruitment of blood donors on the prevalence of HIV and HBV in Bukavu, DR Congo. Med Sante Trop 2012; 22 (1): 69-74.
105. Lohoues-Kouacou MJ, Toure M, Hillah J, et al,. Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination. Sante 1998; 8 (6): 401-404. (Pubitemid 29474108)
106. Combe P, La Ruche G, Bonard D, et al,. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Cote d'Ivoire, West Africa. Trans R Soc Trop Med Hyg 2001; 95 (5): 493-496. (Pubitemid 34947402)
107. Ramos JM, Toro C, Reyes F, Amor A, Gutierrez F,. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol 2011; 51 (1): 83-85.
108. Tiruneh M,. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiop Med J 2008; 46 (4): 359-366.
109. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT,. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 2003; 131 (1): 757-770. (Pubitemid 37062899)
110. Tesfa H, Biadgo B, Getachew F, Tegegne K, Yismaw G, Muluye D,. Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital. BMC Res Notes 2013; 6: 164.
111. Shimelis T, Torben W, Medhin G, et al,. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect 2008; 84 (1): 37-41. (Pubitemid 351195851)
112. Duncan ME, Tibaux G, Kloos H, et al,. STDS in women attending family planning clinics: a case study in Addis Ababa. Soc Sci Med 1997; 44 (4): 441-454.
113. Makuwa M, Caron M, Souquiere S, Malonga-Mouelet G, Mahe A, Kazanji M,. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol 2008; 46 (2): 754-756. (Pubitemid 351231330)
114. Candotti D, Danso K, Allain JP,. Maternofetal transmission of hepatitis B virus genotype E in Ghana, West Africa. J Gen Virol 2007; 88 (Pt 10): 2686-2695. (Pubitemid 47555021)
115. Apea-Kubi KA, Yamaguchi S, Sakyi B, Ofori-Adjei D,. HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana. West Afr J Med 2006; 25 (1): 17-21. (Pubitemid 43772817)
116. Dongdem JT, Kampo S, Soyiri IN, Asebga PN, Ziem JB, Sagoe K,. Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009). BMC Res Notes 2012; 5: 115.
117. Okoth F, Mbuthia J, Gatheru Z, et al,. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J 2006; 83 (9): 485-493.
118. Day SL, Odem-Davis K, Mandaliya KN, et al,. Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy. PLoS ONE 2013; 8 (3): e59346.
119. Migliani R, Rakoto Andrianarivelo M, Rousset D, Rabarijaona L, Randrianarisoa P, Roux JF,. Seroprevalence of viral hepatitis B in the city of Mahajanga, Madagascar in 1999. Med Trop (Mars) 2000; 60 (2): 146-150.
120. Ahmed SD, Cuevas LE, Brabin BJ, et al,. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998; 37 (3): 248-251. (Pubitemid 29017271)
121. Chasela CS, Kourtis AP, Wall P, et al,. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol 2014; 60 (3): 508-514.
122. Sidibe S, Sacko BY, Traore I,. Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali. Bull Soc Pathol Exot 2001; 94 (4): 339-341. (Pubitemid 33739531)
123. MacLean B, Hess RF, Bonvillain E, et al,. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J 2012; 102 (1): 47-49.
124. Mansour W, Malick FZ, Sidiya A, et al,. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 2012; 84 (8): 1186-1198.
125. Saindou M, Benet T, Troalen D, et al,. Prevalence and risk factors for HIV, hepatitis B virus, and syphilis among pregnant women in Mayotte, Indian Ocean, 2008-2009. Int J Gynaecol Obstet 2012; 119 (1): 61-65.
126. Cunha L, Plouzeau C, Ingrand P, et al,. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007; 79 (12): 1832-1840. (Pubitemid 350006307)
127. Mamadou S, Ide M, Maazou AR, Aoula B, Labo S, Bozari M,. HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa. HIV AIDS (Auckl) 2012; 4: 1-4.
128. Olaleye OA, Kuti O, Makinde NO, et al,. Perinatal transmission of hepatitis B virus infection in Ile-Ife, South Western, Nigeria. J Neonatal Perinatal Med 2013; 6 (3): 231-236.
129. Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C,. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J 2011; 8: 12.
130. Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO,. Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet Gynecol Scand 2010; 89 (8): 1024-1028.
131. Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI,. Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J 2012; 9: 317.
132. Olokoba AB, Salawu FK, Danburam A, et al,. Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria- a call for action. Niger J Clin Pract 2011; 14 (1): 10-13.
133. Akani CI, Ojule AC, Opurum HC, Ejilemele AA,. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J 2005; 12 (4): 266-270.
134. Buseri F, Seiyaboh E, Jeremiah Z,. Surveying Infections among Pregnant Women in the Niger Delta, Nigeria. J Glob Infect Dis 2010; 2 (3): 203-211.
135. Okeke TC, Obi SN, Okezie OA, et al,. Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria. Niger J Med 2012; 21 (1): 57-60.
136. Adesina O, Oladokun A, Akinyemi O, et al,. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan. Afr J Med Med Sci 2010; 39 (4): 305-310.
137. Forbi JC, Onyemauwa N, Gyar SD, Oyeleye AO, Entonu P, Agwale SM,. High prevalence of hepatitis B virus among female sex workers in Nigeria. Rev Inst Med Trop Sao Paulo 2008; 50 (4): 219-221.
138. Sirisena ND, Njoku MO, Idoko JA, et al,. Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria. Niger Postgrad Med J 2002; 9 (1): 7-10.
139. Jombo GT, Egah DZ, Banwat EB,. Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 2005; 14 (4): 425-428.
140. Otegbayo JA, Taiwo BO, Akingbola TS, et al,. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 2008; 7 (2): 152-156. (Pubitemid 351845527)
141. Adoga MP, Gyar SD, Pechulano S, et al,. Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests. J Infect Dev Ctries 2010; 4 (6): 397-400.
142. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ,. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Afr Health Sci 2012; 12 (3): 312-317.
143. Nwokedi EE, Emokpae MA, Dutse AI,. Human immunodeficiency virus and hepatitis B virus co-infection among patients in Kano Nigeria. Niger J Med 2006; 15 (3): 227-229.
144. Pirillo MF, Bassani L, Germinario EA, et al,. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007; 79 (12): 1797-1801. (Pubitemid 350006301)
145. Bovet P, Yersin C, Herminie P, Lavanchy D, Frei PC,. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bull World Health Organ 1999; 77 (11): 923-928.
146. Torlesse H, Wurie IM, Hodges M,. The use of immunochromatography test cards in the diagnosis of hepatitis B surface antigen among pregnant women in West Africa. Br J Biomed Sci 1997; 54 (4): 256-259. (Pubitemid 28025074)
147. Burnett RJ, Ngobeni JM, Francois G, et al,. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 2007; 18 (3): 152-156. (Pubitemid 351739041)
148. Andersson MI, Maponga TG, Ijaz S, et al,. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine 2013; 31 (47): 5579-5584.
149. Andersson MI, Maponga TG, Ijaz S, Theron G, Preiser W, Tedder RS,. High HBV viral loads in HIV-infected pregnant women at a Tertiary Hospital, South Africa. J Acquir Immune Defic Syndr 2012; 60 (4): e111-e112.
150. Boyles TH, Cohen K,. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J 2011; 101 (7): 470-471.
151. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I,. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J 2007; 4: 104.
152. Ahmed Elmukashfi T, Ali Ibrahim O, Elkhidir IM, Ali Bashir A, Ali Awad Elkarim M,. Socio-demographic characteristics of health care workers and hepatitis B virus (HBV) infection in public teaching hospitals in Khartoum State, Sudan. Glob J Health Sci 2012; 4 (4): 37-41.
153. Dziuban EJ, Marton SA, Hughey AB, Mbingo TL, Draper HR, Schutze GE,. Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland. Int J STD AIDS 2013; 24 (7): 561-565.
154. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al,. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58 (3): 215-220. (Pubitemid 29278022)
155. Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I, Schreier E,. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol 2000; 62 (4): 524-530.
156. Msuya SE, Mbizvo EM, Hussain A, Sam NE, Stray-Pedersen B,. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban,
157. Jacobs B, Mayaud P, Changalucha J, et al,. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis 1997; 24 (3): 121-126. (Pubitemid 27123186)
158. Matee MI, Magesa PM, Lyamuya EF,. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006; 6: 21.
159. Seremba E, Ocama P, Opio CK, et al,. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda. J Med Virol 2010; 82 (8): 1334-1340.
160. Ochola E, Ocama P, Orach CG, et al,. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health 2013; 13: 727.
161. Stabinski L, Reynolds SJ, Ocama P, et al,. Hepatitis B virus and sexual behavior in Rakai, Uganda. J Med Virol 2011; 83 (5): 796-800.
162. Oshitani H, Kasolo F, Tembo C, et al,. Hepatitis B virus infection among pregnant women in Zambia. East Afr Med J 1995; 72 (12): 813-815.
163. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA,. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 1999; 45 (8): 195-198.
164. Tswana SA, Nystrom L, Moyo SR, Nzara MJ, Chieza L, Tianani J,. A sero-epidemiology cross-sectional nationwide study of the prevalence of human immunodeficiency virus in Zimbabwe 1989-1991. Afr J Health Sci 1996; 3 (3): 96-100. (Pubitemid 126143436)
165. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM,. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998; 147 (5): 478-487. (Pubitemid 28146108)
166. Dumpis U, Holmes EC, Mendy M, et al,. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 2001; 35 (1): 99-104. (Pubitemid 32646231)
167. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J,. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999; 58 (2): 111-115. (Pubitemid 29226851)
168. Viviani S, Mendy M, Jack AD, Hall AJ, Montesano R, Whittle HC,. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia. Trop Med Int Health 2004; 9 (10): 1044-1049. (Pubitemid 39423082)